Human Vaccines

Global Human Vaccines Market to Reach US$71.4 Billion by 2030

The global market for Human Vaccines estimated at US$46.9 Billion in the year 2024, is expected to reach US$71.4 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Intramuscular & Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by the end of the analysis period. Growth in the Oral Administration segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$12.4 Billion While China is Forecast to Grow at 11.7% CAGR

The Human Vaccines market in the U.S. is estimated at US$12.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$16.8 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Human Vaccines Market - Key Trends and Drivers Summarized

Unveiling the Power of Human Vaccines: A Cornerstone of Modern Medicine

Human vaccines stand as one of the greatest achievements in public health, offering protection against a myriad of infectious diseases by training the immune system to recognize and combat pathogens. Comprising antigens that mimic disease-causing organisms, vaccines are crucial in preparing the immune system to fight diseases quickly and effectively. This mechanism has successfully led to the eradication and reduction of numerous life-threatening diseases, such as smallpox and polio, significantly lowering morbidity and mortality worldwide. Vaccines not only safeguard individuals but also contribute to herd immunity, preventing the spread of infections across communities and thereby securing population health globally.

Navigating New Frontiers: Innovations Enhancing Vaccine Efficacy and Safety

The landscape of vaccine technology is constantly evolving, incorporating novel methods that promise greater protection and safety. Traditional vaccine strategies, while effective, are now being enhanced with cutting-edge approaches like mRNA vaccines and recombinant technologies. These innovations offer precise targeting and rapid scalability, particularly highlighted by their role in addressing global challenges such as the COVID-19 pandemic swiftly. Furthermore, the development of adjuvants and improved delivery systems continues to revolutionize vaccine efficacy, broadening the horizons for combating more complex diseases and tailoring immunizations to diverse populations.

Emerging Trends Reshaping the Global Vaccine Sector

Global demographic and technological trends are reshaping the vaccine industry. The increase in international travel and urbanization elevates the risk of infectious disease transmission, amplifying the need for effective vaccination programs. Simultaneously, rising health consciousness and improved healthcare infrastructure are driving up vaccine uptake globally, especially in regions previously underserved. Technological advancements such as digital immunization tracking and AI in healthcare are also enhancing the reach and efficiency of vaccination campaigns, ensuring wider and more effective coverage.

What Drives the Growth in the Human Vaccines Market?

The growth in the human vaccines market is driven by several factors, including the increasing prevalence of infectious diseases, rising global health awareness, and advancements in vaccine research and development. Enhanced funding and investments by governments and global health organizations to eliminate infectious diseases contribute significantly to the expansion and innovation within the vaccine sector. The COVID-19 pandemic has particularly highlighted the critical role of vaccines in global health security, leading to unprecedented public and private partnerships focused on vaccine development and distribution. Moreover, demographic factors such as aging populations and the rise in chronic health conditions that increase susceptibility to infections necessitate continued vaccine development and uptake. Together, these dynamics underscore the vital role of vaccines in contemporary medicine and public health, ensuring ongoing investment and research in this essential field.

SCOPE OF STUDY:

The report analyzes the Human Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Administration Route (Intramuscular & Subcutaneous, Oral, Other Administration Routes); Technology (Conjugate, Recombinant, Inactivated & Subunit, Live Attenuated, Other Technologies)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

• ALK - Abelló A/S
• Altimmune, Inc.
• Astellas Pharma Inc.
• Bavarian Nordic A/S
• Bharat Biotech
• BiondVax Pharmaceuticals Ltd.
• GlaxoSmithKline Plc
• Hualan Biological Engineering Inc.
• Janssen Pharmaceuticals Inc.
• MedImmune
• Mitsubishi Tanabe Pharma
• Pfizer Inc.
• Sanofi Pasteur SA
• Seqirus
• Serum Institute of India Pvt. Ltd.
• SK BioScience
• Takeda Pharmaceutical Company Limited
• Zydus Cadila

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.